Salarius Pharmaceuticals, Inc.·4

Nov 5, 5:42 PM ET

Rosenblum Mark J 4

4 · Salarius Pharmaceuticals, Inc. · Filed Nov 5, 2020

Insider Transaction Report

Form 4
Period: 2020-11-03
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
  • Award

    Common Stock

    2020-11-03$0.56/sh+4,723$2,65016,723 total
Footnotes (1)
  • [F1]The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan.

Documents

1 file
  • 4
    wf-form4_160461612138517.xmlPrimary

    FORM 4